Roche Tarceva News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche tarceva. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Tarceva Today - Breaking & Trending Today

AstraZeneca drug Tagrisso gets EU nod for early lung cancer treatment


By Syndicated Content
May 28, 2021 | 2:06 AM
(Reuters) – AstraZeneca’s top-selling Tagrisso drug has been approved for use in the European Union to treat patients with a type of early-stage lung cancer, the company said on Friday.
The European Commission has approved the lung cancer drug as an add-on treatment for adults diagnosed early enough for the tumour to be surgically removed, and who have a mutation of the EGFR gene, the British drugmaker said.
The approval was based on positive results from a late-stage trial called ADAURA, which showed Tagrisso cut the risk of the tumour growing back in patients or death by 80%. ....

United States , United Kingdom , Roche Tarceva , Devika Syamnath , Astrazeneca Iressa , Vishwadha Chander , European Union , European Commission , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஐரோப்பிய தொழிற்சங்கம் , ஐரோப்பிய தரகு ,

AstraZeneca's drug Tagrisso gets China nod for early lung cancer


By Reuters Staff
1 Min Read
FILE PHOTO: The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski
(Reuters) -AstraZeneca Plc said on Wednesday that China’s health regulator expanded the use of Tagrisso, the British drugmaker’s lung cancer treatment, in patients with a type of lung cancer when diagnosed at an early stage.
China’s National Medical Products Administration (NMPA) approved Tagrisso as an adjuvant therapy for patients with early-stage lung cancer who have a mutation of the EGFR gene, AstraZeneca said.
The drug is now approved to treat early-stage lung cancer in more than a dozen countries, including, most recently, in the United States. ....

United States , United Kingdom , Roche Tarceva , Shailesh Kuber , Vishwadha Chander , Thomson Reuters Trust Principles , China National Medical Products Administration , Astrazeneca Plc , National Medical Products Administration , Thomson Reuters Trust , Asia Pacific , China Prc , Health Medicine , Healthcare Trbc Level 1 , Medical Regulation , Biotechnology Amp Medical Research Trbc Level 4 , Pharmaceuticals Trbc Level 4 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Corporate Market Regulation , Reuters Top News , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஷைலேஷ் குபர் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை , ஆசியா பெஸிஃபிக் ,